Rare diseases
Investigational molecules
Locations
Back to Germany574 clinical trials in Ulm, Germany across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke
GermanyStudy on the Effects of MORF-057 for Adults with Moderate to Severe Ulcerative Colitis
GermanyStudy on the Effects of Eclitasertib in Adults with Moderate to Severe Ulcerative Colitis
GermanyStudy on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults
GermanyStudy of Atezolizumab with Lenvatinib or Sorafenib vs Lenvatinib or Sorafenib alone in Unresectable Hepatocellular Carcinoma after Atezolizumab and Bevacizumab
GermanyA study to evaluate the efficacy and safety of vixarelimab in patients with moderate to severe ulcerative colitis
GermanyA Phase 3 Randomized Open-Label Study of Sacituzumab Govitecan Versus Physician's Choice in Recurrent or Persistent Endometrial Cancer Post-Chemotherapy and Immunotherapy
GermanyEvaluation of Safety and Efficacy of Zilovertamab Vedotin and Nemtabrutinib in Aggressive and Indolent B-cell Malignancies
GermanyA Study of Mevrometostat and Enzalutamide for Men with Metastatic Castration-Sensitive Prostate Cancer Who Have Not Received Hormonal Therapy or Chemotherapy
GermanyStudy of Trontinemab Compared to Placebo for Patients with Early Symptomatic Alzheimer's Disease
GermanyA study testing trontinemab compared to placebo in patients with early Alzheimer's disease including mild cognitive impairment and mild dementia
GermanyA Study Comparing Two Forms of Ocrelizumab Given Under the Skin in Patients with Multiple Sclerosis
GermanyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking trials focusing on colorectal cancer, acute myeloid leukemia, and various types of lymphomas. Studies are evaluating novel combination therapies and targeted treatments for patients with specific genetic mutations.
Multiple trials investigating innovative treatment approaches for blood cancers and solid tumors.
Clinical research targeting multiple sclerosis, Alzheimer's disease, and amyotrophic lateral sclerosis. Studies are exploring new therapeutic agents and diagnostic tools.
Innovative approaches in neurodegenerative disease management and treatment.
Comprehensive studies on inflammatory bowel diseases, rheumatoid arthritis, and Sjögren's disease. Research focuses on novel biological therapies and long-term treatment options.
Advanced therapeutic approaches for chronic inflammatory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
